Provided by Tiger Trade Technology Pte. Ltd.

AEON Biopharma

0.2020
+0.00462.33%
Volume:38.72M
Turnover:9.88M
Market Cap:10.08M
PE:-0.06
High:0.3296
Open:0.2029
Low:0.1900
Close:0.1974
52wk High:1.45
52wk Low:0.1772
Shares:49.88M
Float Shares:30.51M
Volume Ratio:7.58
T/O Rate:126.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5840
EPS(LYR):-3.9532
ROE:--
ROA:-141.53%
PB:-0.66
PE(LYR):-0.05

Loading ...

Aug 21, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 12, 2026

Major Issues Report

Form 8-K - Current report
Aug 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2026

Major Issues Report

Form 8-K - Current report
Jul 24, 2026

Major Issues Report

Form 8-K - Current report
Jul 21, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jul 16, 2026

Major Issues Report

Form 8-K - Current report
Jul 09, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 08, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 18, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2026

Major Issues Report

Form 8-K - Current report
Apr 03, 2026

Major Issues Report

Form 8-K - Current report
Mar 31, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 31, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Mar 10, 2026

Major Issues Report

Form 8-K - Current report
Feb 13, 2026

Correspondence

Form CORRESP - Correspondence
Jan 21, 2026

Major Issues Report

Form 8-K - Current report